REG-Convatec Group PLC Convatec Group PLC: Scrip Dividend - Calculation Price

ConvaTecAnnouncement

17/04/2023 17:00

============

   Convatec Group PLC (CTEC)
   Convatec Group PLC: Scrip Dividend - Calculation Price

   17-Apr-2023 / 16:55 GMT/BST

   ══════════════════════════════════════════════════════════════════════════

                       Scrip Dividend – calculation price

    

   Reading, United Kingdom (17 April 2023)

   On 8 March 2023, the Board of Directors of Convatec Group Plc  (“Convatec”
   or “the  Company”) proposed  a final  dividend of  4.330 cents  per  share
   (“Final Dividend”), subject to approval at the forthcoming Annual  General
   Meeting on 18 May 2023. This Final Dividend  is to be paid on 25 May  2023
   to shareholders on the share register as of 11 April 2023 (“Record Date”).
   The Final Dividend is payable in cash, in sterling to holders of  ordinary
   shares. The  chosen  exchange  rate  for  this  payment  is  $1.184/£1.00,
   determined  on  8  March  2023,  giving  a  total  sterling  dividend   of
   £74,744,400.80 A  scrip dividend  will be  made available  for this  Final
   Dividend, allowing shareholders to elect to receive their dividend in  the
   form of new ordinary shares.

   The “Calculation Price”  for the issue  of new ordinary  shares under  the
   scrip dividend scheme is:

                    221.2 pence for each new ordinary share.

     This is equivalent to 1 new share for approximately 60.49 shares held
                 prior to the ex-dividend date of 6 April 2023.

   The Calculation Price is the average of the middle market quotations of  a
   Convatec share,  derived from  the London  Stock Exchange  Daily  Official
   List, for the five consecutive business days from 6 April to 14 April 2023
   (inclusive).

   The latest  date for  receipt of  elections to  participate in  the  scrip
   dividend scheme for the  Final Dividend is 3  May 2023. Shareholders  must
   return their mandate  form by  5pm (BST)  or otherwise  input their  CREST
   elections to be received by the Company’s registrar, Computershare, by 3pm
   (BST). Elections received  after this  deadline will  apply to  subsequent
   dividends only. Unless revoked by a shareholder, a scrip dividend election
   will apply for all future dividends for which a scrip dividend is offered.
   Evergreen  elections  for  CREST  shareholders  cannot  be  accepted   and
   elections will  revert  to cash  by  default  after the  payment  of  each
   dividend.

   Details   of    the   scrip    dividend    scheme   are    available    at
    1 www.convatecgroup.com/investors.

   TIMETABLE

   Key dates in respect of the  scrip dividend scheme for the Final  Dividend
   are:

   Ex-dividend Date                                      6 April 2023

   Record Date                               11 April 2023

   Scrip calculation price determined                                        
         6 April - 14 April 2023 (inclusive)

   Scrip calculation price available and announced              17 April 2023

   Mandate delivery deadline for Shares held in uncertificated form          
   3.00 p.m. on 3 May 2023

   Mandate delivery deadline for  Shares held in certificated  form          
      5.00 p.m. on 3 May 2023 

   Announcement of the total amount of new shares to be issued               
   9 May 2023

   Dividend payment date                  25 May 2023

   Dispatch of statement in accordance with section 7 of Scheme              
       25 May 2023

   Rules and share certificates, CREST accounts credited/updated

   Enquiries 

    

   Louise Bryson, Assistant Company
   Secretary                                            +44(0)7423 694919

    

   Cosec@convatec.com 

    

   Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92 

    

   About Convatec 
    

   Pioneering trusted  medical  solutions  to improve  the  lives  we  touch:
   Convatec is a global medical products

   and technologies  company,  focused on  solutions  for the  management  of
   chronic conditions, with leading positions in advanced wound care,  ostomy
   care, continence and critical care, and infusion care. With around  10,000
   colleagues, we provide our products and services in almost 100  countries,
   united by a promise to be forever caring. Our solutions provide a range of
   benefits, from infection  prevention and  protection of  at-risk skin,  to
   improved patient outcomes and reduced  care costs. Group revenues in  2022
   were over $2 billion. The company is  a constituent of the FTSE 100  Index
   (LSE:CTEC).   To    learn    more    about    Convatec,    please    visit
    2 http://www.convatecgroup.com

    

   ══════════════════════════════════════════════════════════════════════════

   Dissemination of a Regulatory Announcement, transmitted by EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   ISIN:          GB00BD3VFW73
   Category Code: DIV
   TIDM:          CTEC
   LEI Code:      213800LS272L4FIDOH92
   Sequence No.:  237436
   EQS News ID:   1609573


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    3 fncls.ssp?fn=show_t_gif&application_id=1609573&application_name=news&site_id=refinitiv2

References

   Visible links
   1. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=cd503027e07da3a35980bba88dbdb093&application_id=1609573&site_id=refinitiv2&application_name=news
   2. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=26f8de477e9a42123589f91471356e0b&application_id=1609573&site_id=refinitiv2&application_name=news


============